Table 2. Clinical characteristics of the OxVALVE subset stratified according to E/e’ ratio
CharacteristicNormal E/e’ (<8)Intermediate E/e’ (8–14)High E/e’ (>14)P value
Participants, n a 3917358
Age, years, median (IQR)71 (68–76)72 (68–77)76 (71–83)<0.001b
Sex, n (%)0.045c
 Male25 (64.1)100 (57.8)24 (41.4)
 Female14 (35.9)73 (42.2)34 (58.6)
NYHA class, n (%)0.098c
 I25 (64.1)121 (69.9)29 (50.0)
 II12 (30.8)47 (27.2)26 (44.8)
 III2 (5.1)5 (2.9)3 (5.2)
Ejection fraction, %, median (IQR)69 (65–72)69 (66–73)68 (65–74)0.97b
FeNO, ppb, median (IQR)19 (17–31)21 (14–29)19 (14–27)0.74b
  • aSeven (2.5%) participants did not have E/e’ measured. bKruskal-Wallis test for independent association of continuous variable with E/e’ strata. cχ2 test for independent association of categorical variables with E/e’ strata. FeNO = fractional exhaled nitric oxide. IQR = interquartile range. NYHA = New York Heart Association. ppb = parts per billion.